newsfilter
← Latest News
Business Wire·

4D pharma to Present at the H.C. Wainwright Global Investment Conference

4D pharma plc ((AIM: DDDD, NASDAQ:LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced that Duncan Peyton, Chief Executive Officer of 4D pharma